Efficacy of Phycocyanin and Palmitoylethanolamide for the Treatment of Chronic Prostatitis Symptoms
Status:
COMPLETED
Trial end date:
2023-09-30
Target enrollment:
Participant gender:
Summary
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a bothering condition characterized by pain localized to the pelvic, perineal and/or genital area and lower urinary tract symptoms (LUTS). Phytotherapy, which involves the combination of two or more active compounds, can be used to treat this challenging condition.
The aim of this study was to investigate the role of an association of phycocyanin (PC) and palmitoylethanolamide (PEA) and selenium (FICOXPEA) in male patients affected by CP/CPPS.
The main questions the present study aims to answer are:
* Does FICOXPEA enhance quality of life of CPP/CPPS patients?
* Does it help reducing pain symptoms of CPP/CPPS patients?
Researchers will investigate whether FICOXPEA works to treat CPP/CPPS symptoms, so its efficacy, but also its tolerability and adherence to therapy.
Participants will:
* Take FICOXPEA once a day for 30 days;
* Visit the clinic for follow-up visits at 1 and 3 months;
* Answer validated questionnaires and declare potential adverse events at follow-up visits.
Phase:
PHASE4
Details
Lead Sponsor:
Clinica Urologica Molinette - Citt della Saliute e della Scienza
Collaborator:
A.O.U. Citt della Salute e della Scienza - Molinette Hospital